HSBC Global Asset Management announces the appointments of Nathalie Flury (pictured left) and Michael Schröter (pictured right) as Co-Heads of Sustainable Healthcare Equity, reporting to Vis Nayar, European & UK Chief Investment Officer. Based in Switzerland, Flury and Schröter will be responsible for establishing a sustainable healthcare investment strategy which will include the creation of sustainable healthcare strategies.
With over 40 years of combined healthcare expertise, they both join from Viopas Partners, a Swiss-based asset manager dedicated to sustainable healthcare investments. Before joining Viopas, Flury was the portfolio manager for the Pictet Asset Management, Health and Biotech fund, prior to which she managed similar funds at GAM and Clariden. Schröter’s previous roles include developing innovative pricing solutions to ensure access and affordability as Head of Personalized Reimbursement Models at Roche and Head of the Oncology Diagnostic R&D Center at Eli Lilly in Singapore.
The strategy will integrate a sustainable investing approach tailored to healthcare which aims to drive social impact without sacrificing performance. It is based on the macroeconomic trend of rising healthcare costs resulting in access restrictions which hurts patients, physicians, the industry and investors. The strategy will invest in a balanced portfolio of companies offering affordable innovation with distinct clinical differentiation. It will offer both wholesale and institutional investors access to an investment process aligned with Good Health & Wellbeing, which is goal three of the United Nations’ Sustainable Development Goals.